Share Buy-backs: The One Mechanism With No Valuer Mandate At All

A company's power to buy back its own securities sits in Section 68 of the Companies Act, 2013, with the procedure for private and unlisted public companies set out in Rule 17 of the Companies (Share Capital and Debentures) Rules, 2014.

Checked directly against the current text of Rule 17: the words "valuation," "valuer," and "registered valuer" do not appear anywhere in it. What it actually requires is two separate, narrower things.

• Disclosure, not certification. The explanatory statement to the notice convening the buy-back meeting must state the buy-back price and the basis for arriving at it. Nobody has to certify that basis is fair.
• The auditor's report, on a different question entirely. The company's auditors must certify that they have inquired into the state of the company's affairs, that the permissible capital payment is properly determined, that the accounts used are not more than six months old, and that the company will not be rendered insolvent within a year. That is a solvency and quantum check on the total amount being spent, not a fairness opinion on the per-share price.

Compare this to Section 62(1)(c) preferential allotments, where Rule 13(2)(g) explicitly requires a registered valuer's report before the price is fixed. Rule 17 has no equivalent. A company can set its own buy-back price, disclose the basis, and proceed, as long as the auditor is satisfied the company can afford it.

Listed companies buy back shares under the SEBI (Buy-Back of Securities) Regulations, 2018, through one of two routes.

• Tender offer: price is set within SEBI's own pricing framework, with a merchant banker managing the offer process. The merchant banker is administering the offer, not issuing a fairness opinion on price the way a registered valuer does for infrequently traded shares under the Takeover Code.
• Open market, through the stock exchange: capped at a percentage of paid-up capital plus free reserves set by SEBI's regulations. The price is whatever the market trades at. There is nothing to value independently because the market is already doing the price discovery.

Neither route carries a registered-valuer requirement. So the answer is the same on both sides of the listed and unlisted line, for different structural reasons: no market price to defer to for unlisted companies, and either a regulated formula or an actual trading market for listed ones.

This is not a gap in drafting. It follows from what a registered-valuer mandate is actually protecting against.

A preferential allotment dilutes the shareholders who are not part of it. They have no say in the price and no opportunity to participate, so the law inserts an independent valuer between the company and the incoming investor to stop the existing shareholders from being diluted at an unfair price. Sweat equity has the same problem in reverse: shares are being handed out for something other than cash, so an independent valuer checks both the share price and the thing being paid for. SEBI's schemes and takeover rules exist for the same reason, protecting shareholders who are not the ones negotiating the deal.

A buy-back does not have that structural problem. Every shareholder gets the same opportunity to participate, pro rata, on the same terms, and nobody is forced to sell. The people the law is actually worried about in a buy-back are the company's creditors, since cash is leaving the company to pay off shareholders instead of being available to pay debts. That is exactly what the solvency declaration and the auditor's certificate are for. A registered valuer's fairness opinion would be solving a problem the buy-back mechanism does not have.

• Not being a legal mandate does not mean a valuation is pointless for a buy-back. A defensible, methodology-backed price is exactly what gives the auditor's "properly determined" certification something rigorous to rely on, and it is what a board would want on file if the price is ever questioned.
• It does mean the two engagements are legally different things wearing the same DCF methodology. One is a statutory requirement with a specific rule behind it. The other is good governance practice with no rule mandating it at all.

The same distinction runs through the rest of this series: ESOP and buy-backs both turn out to have no company-law valuer mandate, while sweat equity and preferential allotments both require one. The pattern is never about the size of the transaction. It is always about who the law is trying to protect.

The income tax side lines up the same way. Buy-backs are excluded from both Section 50CA and Section 56(2)(x), the two provisions covered in Angel Tax Is Abolished. Rule 11UA Isn't, since Section 115QA governs buy-back taxation on its own, non-obstante terms. No valuer mandate on the company-law side, and no Rule 11UA exposure on the tax side either.

Mergers land closer to the middle than either extreme, covered in Merger Valuations: Conditional Under Company Law, Mandatory Under SEBI. Company law makes the valuation report conditional, "if any," rather than a firm mandate, but the mechanics of setting a share exchange ratio make one practically unavoidable regardless of what the statute compels.

A buy-back is also the clean contrast case for control premium: since every shareholder gets the same pro-rata offer and nobody's control position changes, there is no control premium or discount for lack of control to consider in the first place, unlike a merger. That contrast, and where the question does apply, is covered in Control Premium: Explicit Duty Under IBC, Implicit Duty Everywhere Else.

A preference share redemption sits in the same "nothing left to price" family, for a related reason, covered in Preference Shares Are an SFA Valuer's Job. Redemption Isn't..